Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proseed Venture Capital Fund is an Israel-based investment firm that specializes in early-stage and growth-stage companies within the life sciences and high-tech sectors. The fund focuses on identifying innovative medical technologies, biotechnology platforms, and healthcare solutions, primarily within the Israeli ecosystem. Proseed provides both financial capital and strategic guidance to its portfolio companies to facilitate clinical development and market entry. Notable investments in the life sciences space include companies focused on drug delivery, medical devices, and specialized pharmaceutical formulations. The fund is publicly traded on the Tel Aviv Stock Exchange under the symbol PRSD.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proseed Capital Holdings.